Jonathan Van-Tam on COVID’s Next Phase
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
False
Advertisement
Related Content
Cell & Gene
Power List
Development & Clinical
Musings from The Power List: John Maher
August 14, 2026
4 min read
John Maher discusses the scientific and practical challenges of bringing CAR T-cell therapies to patients with solid tumors
Development & Clinical
Regulation & Standards
Business & Trends
From Training Burden to Training Value
August 14, 2026
0 min read
Why effective study training depends on relevance, timing, and oversight.
Cell & Gene
Development & Clinical
Interviews
Why Cell Therapy Needs a Digital Backbone
August 13, 2026
8 min read
Alexander Seyf on why the UK is losing ground in cell and gene therapy, the real bottlenecks to commercialization, and why digitalization is no longer optional
Outsourcing
Biopharma
Business & Trends
Musings from The Power List: Ali Pashazadeh
August 7, 2026
7 min read
Ali Pashazadeh argues that management failures sink too many clinical programs – and explains why commercial discipline must start much earlier